159 related articles for article (PubMed ID: 9925232)
21. Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine.
Sethi A; Chandra D; Puri V; Mallika V
Neurol India; 2002 Sep; 50(3):359-63. PubMed ID: 12391470
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations.
Handforth A; Treiman DM
Epilepsia; 1994; 35(5):1032-7. PubMed ID: 7925148
[TBL] [Abstract][Full Text] [Related]
23. Long-term study with gabapentin in patients with drug-resistant epileptic seizures.
Sivenius J; Ylinen A; Kälviäinen R; Riekkinen PJ
Arch Neurol; 1994 Oct; 51(10):1047-50. PubMed ID: 7945002
[TBL] [Abstract][Full Text] [Related]
24. Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 88/89.
Bergey GK; Morris HH; Rosenfeld W; Blume WT; Penovich PE; Morrell MJ; Leiderman DB; Crockatt JG; LaMoreaux L; Garofalo E; Pierce M
Neurology; 1997 Sep; 49(3):739-45. PubMed ID: 9305334
[TBL] [Abstract][Full Text] [Related]
25. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83.
Beydoun A; Fischer J; Labar DR; Harden C; Cantrell D; Uthman BM; Sackellares JC; Abou-Khalil B; Ramsay RE; Hayes A; Greiner M; Garofalo E; Pierce M
Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335
[TBL] [Abstract][Full Text] [Related]
26. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.
Chadwick DW; Anhut H; Greiner MJ; Alexander J; Murray GH; Garofalo EA; Pierce MW
Neurology; 1998 Nov; 51(5):1282-8. PubMed ID: 9818846
[TBL] [Abstract][Full Text] [Related]
27. [Gabapentin used in 559 patients with partial seizures. A multicenter observation study. Spanish Gabapentin Work Group].
Herranz JL; Sol JM; Hernández G
Rev Neurol; 2000 Jun 16-30; 30(12):1141-5. PubMed ID: 10935239
[TBL] [Abstract][Full Text] [Related]
28. A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy.
Crawford P; Brown S; Kerr M;
Seizure; 2001 Mar; 10(2):107-15. PubMed ID: 11407953
[TBL] [Abstract][Full Text] [Related]
29. Gabapentin as adjunctive therapy for partial seizures.
Bruni J
Epilepsia; 1999; 40 Suppl 6():S27-8; discussion S73-4. PubMed ID: 10530680
[TBL] [Abstract][Full Text] [Related]
30. Conversion from thrice daily to twice daily administration of gabapentin (GBP) in partial epilepsy: analysis of clinical efficacy and plasma levels.
Muscas GC; Chiroli S; Luceri F; Mastio MD; Balestrieri F; Arnetoli G
Seizure; 2000 Jan; 9(1):47-50. PubMed ID: 10667963
[TBL] [Abstract][Full Text] [Related]
31. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group.
Epilepsy Res; 1994 May; 18(1):67-73. PubMed ID: 8088258
[TBL] [Abstract][Full Text] [Related]
32. [Clinical studies on gabapentin in Switzerland].
Shokry A
Praxis (Bern 1994); 1996 Jan; 85(4):94-8. PubMed ID: 8578060
[TBL] [Abstract][Full Text] [Related]
33. Gabapentin as add-on therapy for refractory partial epilepsy: results of five placebo-controlled trials.
Leiderman DB
Epilepsia; 1994; 35 Suppl 5():S74-6. PubMed ID: 8039475
[TBL] [Abstract][Full Text] [Related]
34. Add-on gabapentin for refractory seizures in patients with brain tumours.
Perry JR; Sawka C
Can J Neurol Sci; 1996 May; 23(2):128-31. PubMed ID: 8738926
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group.
Morrell MJ; McLean MJ; Willmore LJ; Privitera MD; Faught RE; Holmes GL; Magnus L; Bernstein P; Rose-Legatt
Seizure; 2000 Jun; 9(4):241-8. PubMed ID: 10880282
[TBL] [Abstract][Full Text] [Related]
36. Gabapentin: discussion.
Fromm GH
Epilepsia; 1994; 35 Suppl 5():S77-80. PubMed ID: 8039476
[TBL] [Abstract][Full Text] [Related]
37. Gabapentin.
McLean MJ
Epilepsia; 1995; 36 Suppl 2():S73-86. PubMed ID: 8784216
[TBL] [Abstract][Full Text] [Related]
38. Clinical efficacy and safety of gabapentin.
Ramsay RE
Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
[TBL] [Abstract][Full Text] [Related]
39. Gabapentin.
Bruni J
Can J Neurol Sci; 1996 Nov; 23(4 Suppl 2):S10-2. PubMed ID: 8951214
[TBL] [Abstract][Full Text] [Related]
40. [Gabapentin--a new antiepileptic agent].
Nakken KO; Rytter E; Johannessen SI
Tidsskr Nor Laegeforen; 1998 Feb; 118(6):872-4. PubMed ID: 9543799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
